Pfizer has spent the past few years trying to convince investors that its post-pandemic business can stand on its own, and ...

The pharmaceutical company has been investing in its future growth, but whether its efforts will pay off is a big question ...

The pharmaceutical giant just extended the lifespan of one of its top drugs.

If you are wondering whether Pfizer's current share price properly reflects its long term potential, the recent share ...

Pfizer's vaccine business cooled off, and it is on its back foot in the GLP-1 race, but don't count the drug giant out.

Pfizer PFE is set to report its first-quarter 2026 earnings on May 5, before market open. The Zacks Consensus Estimate for ...

Pfizer (NYSE: PFE) stock hasn't made for a good investment over the past five years. It has declined by 25% in value over that stretch, while the S&P 500 has climbed by 68%. Investors have lost ...

Pfizer Inc. (NYSE: PFE) is one of the 10 Best Medical Stocks to Buy Under $30. On April 20, Pfizer Inc. (NYSE:PFE) announced, ...

Investors who seek out dividend stocks pay close attention to a company's dividend yield, and high-yield players -- as long ...

Pfizer beat on 2025 sales and beat on earnings -- but still delivered a loss. Pfizer reaffirmed 2026 sales and earnings guidance for under $3 per share. 10 stocks we like better than Pfizer › Pfizer ...

Pfizer’s PFE stock has risen 11% so far in 2026. The stock has also been consistently trading above its 50-day and 200-day simple moving averages (SMAs) since early January. Image Source: Zacks ...